Invention Grant
- Patent Title: Triazole derivatives which are SMO antagonists
- Patent Title (中): 作为SMO拮抗剂的三唑衍生物
-
Application No.: US12082933Application Date: 2008-04-15
-
Publication No.: US07691887B2Publication Date: 2010-04-06
- Inventor: James M. Balkovec , Rolf Thieringer , Sherman T. Waddell
- Applicant: James M. Balkovec , Rolf Thieringer , Sherman T. Waddell
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Matthew A. Leff; David A. Muthard
- Main IPC: A61K31/41
- IPC: A61K31/41 ; A01N43/82 ; A01N43/64

Abstract:
The present invention provides a method for the treatment or prevention of conditions which can be ameliorated by Smo antagonism, which method comprises administration to a patient in need thereof of an effective amount of a compound of formula I or a composition comprising a compound of formula I: or a pharmaceutically acceptable salt or solvate thereof; wherein: 2 of X, Y and Z represent nitrogen atoms, and the other represents an oxygen atom; R1 and R2 are taken together with the atom to which they are attached and represent a cyclobutyl ring, optionally substituted with 1-2 fluorine atoms, and R3 represents hydrogen or a fluorine atom; or R1 represents methyl, R2 represents methyl or a fluorine atom and R3 represents a fluorine atom.
Public/Granted literature
- US20080262051A1 Triazole derivatives which are SMO antagonists Public/Granted day:2008-10-23
Information query